Current Clinical Trials

PAPYRUS HUD
  1. Puneet Khanna, MD
    Puneet Khanna, MD
  2. Rancho Mirage, CA
  3. study started October 2023
  4. Puneet Khanna, MD
  5. Accepting new patients

Description

Summary

The PK Papyrus Covered Coronary Stent System is a balloon­ expandable covered stent that is pre-mounted on a fast-exchange delivery system. The stent is intended for permanent intraluminal placement in the coronary arteries to treat acute coronary artery perforations. A Humanitarian Use Device (HUD) is defined as a medical device intended to benefit patients in the treatment or diagnosis of a disease or condition that affects or is manifested in not more than 8,000 individuals in the United States per year (Orphan Diseases). An HUD is marketed under an HDE and is exempt from the requirement of establishing a reasonable assurance of effectiveness. Although the use of a HUD within its approved labeling does not constitute research, the FDA requires IRB approval be obtained before a HUD can be used in a facility.

Official Title

Humanitarian Use Device (HUD): Biotronik PK Papyrus Covered Coronary Stent System

Lead Scientist at Eisenhower Health

Puneet Khanna, MD
Puneet Khanna, MD, graduated from the Armed Forces Medical College in India. He went on to do his internship and residency in Internal Medicine at the University of Alabama at Birmingham. This was followed by three years of a Fellowship in Cardiology at the University of Southern California and a fourth year of Interventional Cardiology.Dr. Khanna was Board Certified in Internal Medicine in 1990. He is also Board Certified in the subspecialties of Cardiology (1993, 2003), Interventional Cardiolo... more
less

Puneet Khanna, MD, graduated from the Armed Forces Medical College in India. He went on to do his internship and residency in Internal Medicine at the University of Alabama at Birmingham. This was followed by three years of a Fellowship in Cardiology at the University of Southern California and a fourth year of Interventional Cardiology.

Dr. Khanna was Board Certified in Internal Medicine in 1990. He is also Board Certified in the subspecialties of Cardiology (1993, 2003), Interventional Cardiology (1998, 2009), Vascular Medicine (2012) and Endovascular Medicine (2012).

Dr. Khanna has been on staff at Eisenhower Hospital since 1993 and has performed over 10,000 interventional and vascular procedures in his career. He has served in various capacities including as Chief of Cardiology and is currently the Co -Director of the Cardiac Catheterization lab. He has been instrumental in bringing in new technologies to EMC, including directional atherectomy, rotational atherectomy, intra coronary radiation and orbital atherectomy.

In addition to his active practice Dr. Khanna has been personally involved with the evolution and development of new medical devices for the last 15 years. He has  issued and pending patents from the United States Patent & Trademarks  Office  relating to cardiac and vascular devices. He has authored manuscripts, scientific abstracts and articles in peer-reviewed journals. He has been an investigator for leading medical devices and clinical trials and continues to remain active with medical research. He serves on the Scientific Advisory Board of seven different companies.

He is married to Monica Khanna, MD, Chief of Radiation Oncology at Eisenhower Medical and has two children who are currently attending college. "We are blessed to be living in this wonderful valley and to be able to serve our patients in such a great environment" he says. In his free time he loves to golf and ski.

Clinical Study Details

  1. Accepting new patients
  2. study started October 2023
  3. Humanitarian Use Device
  4. May 08, 2025